Kasmi Zakaria, Ain El Hayat Imane, Aadam Zahra, Errami Abderrahmane, Benhsaien Ibtihal, El Bakkouri Jalila, Ben Sabbahia Dalal, Atrassi Meryem, Bousfiha Ahmed Aziz, Ailal Fatima
Laboratory of Clinical Immunology, Inflammation, and Allergy (LICIA), Faculty of Medicine and Pharmacy of Casablanca, Hassan II University, Casablanca, Morocco.
Department of Pediatrics I, Unit of Clinical Immunology and Infectious Diseases, Abderrahim El Harouchi Mother-Children Hospital, Ibn Rochd University Hospital, Casablanca, Morocco.
BMC Med Genomics. 2025 Jan 7;18(1):5. doi: 10.1186/s12920-024-02057-5.
Glycogen Storage Disease Type Ib (GSD-Ib) is a rare autosomal recessive metabolic disorder caused by mutations in SLC37A4, leading to a deficiency in glucose-6-phosphate translocase. This disorder is characterized by impaired glycogenolysis and gluconeogenesis, resulting in clinical and metabolic manifestations. We report a three-month-old Moroccan female patient presenting with doll-like facies, hepatomegaly, dysmorphic features, and developmental delays. Laboratory analysis revealed hypoglycemia, elevated triglyceride levels, hypercalcemia, and neutropenia. Genetic testing confirmed a homozygous pathogenic variant in SLC37A4 and a heterozygous variant of uncertain significance in TBX1. Initial management included a lactose-free and galactose-free diet, multivitamin supplementation, and granulocyte colony-stimulating factor (G-CSF) therapy to address neutropenia. A novel aspect of this case involves hypercalcemia as an unusual finding in GSD-Ib and the co-occurrence of a variant in the TBX1 gene, which is not typically associated with the disease but may contribute to the patient's clinical presentation. These findings add a new dimension to our understanding of GSD-Ib and suggest potential avenues for future research to elucidate these genetic interactions and their impact on clinical outcomes.
1b型糖原贮积病(GSD-Ib)是一种罕见的常染色体隐性代谢紊乱疾病,由SLC37A4基因突变引起,导致葡萄糖-6-磷酸转运酶缺乏。这种疾病的特征是糖原分解和糖异生受损,从而产生临床和代谢表现。我们报告了一名三个月大的摩洛哥女性患者,她表现出娃娃脸、肝肿大、畸形特征和发育迟缓。实验室分析显示低血糖、甘油三酯水平升高、高钙血症和中性粒细胞减少。基因检测证实SLC37A4存在纯合致病性变异,TBX1存在意义不确定的杂合变异。初始治疗包括无乳糖和无半乳糖饮食、多种维生素补充以及粒细胞集落刺激因子(G-CSF)治疗以解决中性粒细胞减少问题。该病例的一个新情况是高钙血症作为GSD-Ib中不寻常的发现,以及TBX1基因变异的同时出现,该基因通常与该疾病无关,但可能导致患者的临床表现。这些发现为我们对GSD-Ib的理解增添了新的维度,并为未来研究阐明这些基因相互作用及其对临床结果的影响提供了潜在途径。